Pressure-flow curves for control and hardened (diamide treated) human RBC's were obtained in capillaries of the isolated rat mesentery, in order to evaluate resistance to flow of hardened RBC's. Blood vessels were maximally dilated by an infusion of 10(-5) mol/l acetylcholine and isoprenaline and perfused with freshly collected human RBC's as well as with RBC's hardened by a treatment (hct 40%; pH 8.0; 37 degree C) with 0.5 mmol/l or 1.5 mmol/l diamide, respectively, suspended in Albumin (0.05%) - Ringer solution. The mesentery was perfused via a hydrostatic pressure reservoir. Arterio-venous pressure difference was varied from 4-10 kPa, and corresponding arteriolo-venular pressure gradients changed from about 200-500 Pa/mm. No significant difference in resistance to flow was observed between control and diamide treated cells over the whole pressure range. However, the flow through the microvascular bed was inhomogeneous upon perfusion with diamide treated cells, caused by a deceleration and stoppage of the cells at capillary narrowing (ratio of cell to vessel diameter greater than 2). The time of stagnation increased with decreasing pressure gradient.

Intravenous thrombolysis performed in Caucasian stroke patients with past or current neoplastic diseases, but not in the course of chemo- and radiotherapy, can be a safe and effective method of treatment. In making decision on the thrombolytic treatment, the risk of bleeding complications and the life expectancy should be assessed.

The indications for intravenous thrombolysis in patients with IS should be strictly analysed so that the treatment is effective and safe especially in older patients, patients with greater severity of neurological symptoms and patients with old post-stroke lesions in baseline CT.

No abstract

The presence of systolic HF, defined according to an old and a new definition, does not determine safety and efficacy of cerebral iv-thrombolysis in patients with IS.